Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating mitoxantrone hydrochloride liposome injection plus capecitabine versus capecitabine alone in recurrent metastatic nasopharyngeal carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Recurrent Metastatic Nasopharyngeal Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING